Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.33 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20160687 | 0.64 | OPRL1 (0.41) | KDM4EALDH1A1 | |
| SCHEMBL13209130 | 0.63 | PIK3CD (0.53) | ALDH1A1 | |
| SCHEMBL8019342 | 0.63 | ALDH1A1 (0.39) | KDM4EALDH1A1SLC29A1POLB | |
| Dimethylaminoethanol SCHEMBL28286375 | 0.62 | MAPT (0.46) | KDM4EALDH1A1SLC29A1POLB | |
| SCHEMBL16840093 | 0.61 | CYP2A13 (0.59) | KDM4EALDH1A1CYP2A13 | |
| Dimethylaminoethanol SCHEMBL11313600 | 0.61 | MAPT (0.50) | KDM4EALDH1A1SLC29A1 | |
| SCHEMBL22749465 | 0.60 | ALDH1A1 (0.50) | KDM4EALDH1A1 | |
| SCHEMBL23810045 | 0.60 | — | — | |
| Trolamine SCHEMBL11804222 | 0.59 | ALDH1A1 (0.43) | KDM4EALDH1A1SLC29A1POLB | |
| SCHEMBL14997478 | 0.59 | ALDH1A1 (0.53) | KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210283273-A1 | NON-VIRAL DELIVERY AGENTS FROM POLYELECTROLYTES BASED ON CYCLOPROPENIUM IONS, THEIR SYNTHESES, AND USES THEREOF | NATIONAL SCIENCE FOUNDATION | 2021-09-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210283273-A1 | NON-VIRAL DELIVERY AGENTS FROM POLYELECTROLYTES BASED ON CYCLOPROPENIUM IONS, THEIR SYNTHESES, AND USES THEREOF | PARG, TET1, PUF60 | KDM4E 726/4885ALDH1A1 2479/4885CYP2A13 4866/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.